• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMC
Click for more information
0.00% 9.6¢

IMMURON LIMITED

Market Cap $21.88M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Biotechnology

Immuron Limited is an Australia-based biopharmaceutical company focused on developing and... Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMC
Banter and General Comments 		15:53 52 19K
15:53 Last post  davide1 Comments Created with Sketch.  52  Views Created with Sketch.  19K 
IMC
Ann: Immuron Plans Phase 2 Trial for IMM-529 following FDA review 		17/09/24 25 6.8K
17/09/24 Last post  awildana Comments Created with Sketch.  25  Views Created with Sketch.  6.8K 
IMC
Ann: Appendix 4E and Preliminary Final Report 		31/08/24 10 2.6K
Metals & Mining SECTOR NEWS

Second round assay results shapes promising greenfields gold discovery at Claw Gold Project

Read More   right-arrow Created with Sketch.
BPM
20 Sep 2024
BPM MINERALS LIMITED
31/08/24 Last post  DSell Comments Created with Sketch.  10  Views Created with Sketch.  2.6K 
IMC
Ann: Immuron CEO presentation to Peak Biotech Showcase 		30/08/24 15 4.2K
30/08/24 Last post  Vivo Comments Created with Sketch.  15  Views Created with Sketch.  4.2K 
IMC
Ann: New US DoD Research Award to develop enhanced Travelan 		21/08/24 19 5.0K
21/08/24 Last post  Odds&Evens Comments Created with Sketch.  19  Views Created with Sketch.  5.0K 
IMC
Clinical Programs 		16/08/24 10 3.6K
16/08/24 Last post  Cornhulio Comments Created with Sketch.  10  Views Created with Sketch.  3.6K 
IMC
News: IMC Immuron Says New US DoD Research Award To Develop Enhanced Travelan 		16/08/24 0 129
16/08/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  129 
IMC
Ann: Immuron Travelan record sales globally, Australia and USA 		15/08/24 23 6.9K
15/08/24 Last post  ich Comments Created with Sketch.  23  Views Created with Sketch.  6.9K 

See All Discussions arrow Created with Sketch.

Timeline

Immuron Plans Phase 2 Trial for IMM-529 following FDA review
05 Sep 16:10
 
Appendix 4E and Preliminary Final Report
30 Aug 09:56
 
Immuron CEO presentation to Peak Biotech Showcase
21 Aug 08:57
 
New US DoD Research Award to develop enhanced Travelan
16 Aug 08:52
 
Immuron CEO presentation to MarketOpen Direct Connect
08 Aug 08:33
 
Immuron CEO to host webinar on MarketOpen Direct Connect
07 Aug 09:46
 
View More arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
(20min delay)
Last
9.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $21.88M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 30000 9.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.9¢ 5000 1
View Market Depth
Last trade - 16.12pm 20/09/2024 (20 minute delay) ?
IMC (ASX) Chart

Top Stories

Essential Energy conference: Streamlining approvals key to the green energy transition

WA Minister for Energy, the Environment and Climate Action Reece Whitby spoke at the RIU energy conference on Wednesday about state policies
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
Essential Energy conference: Elixir talks up QLD's Taroom Trough Elixir Energy Ltd's managing director Neil Young was speaking at RIU's Essential Energy conference in Perth
HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix 88 Energy has posted news of a "significant contingent resource update" for Project Phoenix – but HotCopper users weren't sure.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.